Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery synthesizes new Wee1 inhibitors

May 22, 2019

Toray Industries divulges RORC antagonists

May 22, 2019

Bayer presents compounds for cardiovascular diseases

May 22, 2019

Valneva reports new data from ongoing phase I study of chikungunya vaccine candidate VLA-1553

May 22, 2019

JCR initiates phase I trial of long-acting growth hormone JR-142

May 22, 2019

ABI-009, an mTOR inhibitor, shows promise for treating PAH

May 22, 2019

Allergy Therapeutics reports topline results from phase I study of Acarovac MPL

May 22, 2019

Crinetics begins phase I study of CRN-01941 for neuroendocrine tumors

May 22, 2019

Santhera, University of Basel to work together on gene therapy research for LAMA2 MD

May 22, 2019

Phase III BEACON CRC study of Braftovi triplet therapy meets primary endpoints

May 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...